On 3 May 2021, following the Cancer Research Summit 2021, hosted by the Portuguese Presidency of the European Council, the Porto Declaration on Cancer Research was published as an open call for collective action towards a comprehensive translational cancer research approach focused on personalised and precision medicine and covering the entire cancer research continuum, from prevention to care.
EU-AMRI members: BBMRI for Biobanking and Biomolecular Resources, EATRIS for Translational Research, and ECRIN for multinational Clinical Trials, have endorsed the Declaration while calling for a new level of mobilisation at European level.
Read the EU-AMRI statement here.
For more information please email Anne-Charlotte Fauvel, EATRIS Head of European Affairs, at annecharlottefauvel@eatris.eu.
